Phase 3Recruiting
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Sponsored by University of Texas Southwestern Medical Center
About this study
To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC
Enrolling at this location
Meridian Health System
Neptune City, New Jersey
I'm interestedThis study also enrolls at 39 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.